371 related articles for article (PubMed ID: 26578437)
1. Development of PEGylated peptide probes conjugated with (18)F-labeled BODIPY for PET/optical imaging of MT1-MMP activity.
Kondo N; Temma T; Deguchi J; Sano K; Ono M; Saji H
J Control Release; 2015 Dec; 220(Pt A):476-483. PubMed ID: 26578437
[TBL] [Abstract][Full Text] [Related]
2. In vivo positron emission tomography imaging of protease activity by generation of a hydrophobic product from a noninhibitory protease substrate.
Chuang CH; Chuang KH; Wang HE; Roffler SR; Shiea JT; Tzou SC; Cheng TC; Kao CH; Wu SY; Tseng WL; Cheng CM; Hou MF; Wang JM; Cheng TL
Clin Cancer Res; 2012 Jan; 18(1):238-47. PubMed ID: 22019516
[TBL] [Abstract][Full Text] [Related]
3. Radioiodinated Peptidic Imaging Probes for in Vivo Detection of Membrane Type-1 Matrix Metalloproteinase in Cancers.
Kondo N; Temma T; Shimizu Y; Ono M; Saji H
Biol Pharm Bull; 2015; 38(9):1375-82. PubMed ID: 26328493
[TBL] [Abstract][Full Text] [Related]
4.
Kim H; Kim K; Son SH; Choi JY; Lee KH; Kim BT; Byun Y; Choe YS
ACS Chem Neurosci; 2019 Mar; 10(3):1445-1451. PubMed ID: 30592412
[TBL] [Abstract][Full Text] [Related]
5. A Novel PET Probe for Brown Adipose Tissue Imaging in Rodents.
Wang H; Wang M; Chansaenpak K; Liu Y; Yuan H; Xie J; Yin H; Branca RT; Li Z; Wu Z
Mol Imaging Biol; 2020 Jun; 22(3):675-684. PubMed ID: 31520279
[TBL] [Abstract][Full Text] [Related]
6. Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas.
de Lucas AG; Schuhmacher AJ; Oteo M; Romero E; Cámara JA; de Martino A; Arroyo AG; Morcillo MÁ; Squatrito M; Martinez-Torrecuadrada JL; Mulero F
PLoS One; 2016; 11(7):e0158634. PubMed ID: 27462980
[TBL] [Abstract][Full Text] [Related]
7. Lewis acid-assisted isotopic 18F-19F exchange in BODIPY dyes: facile generation of positron emission tomography/fluorescence dual modality agents for tumor imaging.
Liu S; Lin TP; Li D; Leamer L; Shan H; Li Z; Gabbaï FP; Conti PS
Theranostics; 2013; 3(3):181-9. PubMed ID: 23471211
[TBL] [Abstract][Full Text] [Related]
8. Urokinase injection-triggered clearance enhancement of a 4-arm PEG-conjugated
Matsumura K; Zouda M; Wada Y; Yamashita F; Hashida M; Watanabe Y; Mukai H
Int J Pharm; 2018 Jul; 545(1-2):206-214. PubMed ID: 29746998
[TBL] [Abstract][Full Text] [Related]
9. Bicyclic Peptides as a New Modality for Imaging and Targeting of Proteins Overexpressed by Tumors.
Eder M; Pavan S; Bauder-Wüst U; van Rietschoten K; Baranski AC; Harrison H; Campbell S; Stace CL; Walker EH; Chen L; Bennett G; Mudd G; Schierbaum U; Leotta K; Haberkorn U; Kopka K; Teufel DP
Cancer Res; 2019 Feb; 79(4):841-852. PubMed ID: 30606721
[TBL] [Abstract][Full Text] [Related]
10. MT1-MMP as a PET Imaging Biomarker for Pancreas Cancer Management.
Morcillo MÁ; García de Lucas Á; Oteo M; Romero E; Magro N; Ibáñez M; Martínez A; Garaulet G; Arroyo AG; López-Casas PP; Hidalgo M; Mulero F; Martínez-Torrecuadrada J
Contrast Media Mol Imaging; 2018; 2018():8382148. PubMed ID: 30224904
[TBL] [Abstract][Full Text] [Related]
11. Development of a Radiolabeled Peptide-Based Probe Targeting MT1-MMP for Breast Cancer Detection.
Min K; Ji B; Zhao M; Ji T; Chen B; Fang X; Ma Q
PLoS One; 2015; 10(10):e0139471. PubMed ID: 26437463
[TBL] [Abstract][Full Text] [Related]
12. Optimization of a MT1-MMP-targeting Peptide and Its Application in Near-infrared Fluorescence Tumor Imaging.
Ren L; Wang Y; Zhu L; Shen L; Zhang J; Wang J; Li H; Zheng Q; Yu D; Fang X
Sci Rep; 2018 Jul; 8(1):10334. PubMed ID: 29985410
[TBL] [Abstract][Full Text] [Related]
13. Design strategy for a near-infrared fluorescence probe for matrix metalloproteinase utilizing highly cell permeable boron dipyrromethene.
Myochin T; Hanaoka K; Komatsu T; Terai T; Nagano T
J Am Chem Soc; 2012 Aug; 134(33):13730-7. PubMed ID: 22830429
[TBL] [Abstract][Full Text] [Related]
14. Non-destructive and selective imaging of the functionally active, pro-invasive membrane type-1 matrix metalloproteinase (MT1-MMP) enzyme in cancer cells.
Remacle AG; Shiryaev SA; Golubkov VS; Freskos JN; Brown MA; Karwa AS; Naik AD; Howard CP; Sympson CJ; Strongin AY
J Biol Chem; 2013 Jul; 288(28):20568-80. PubMed ID: 23733191
[TBL] [Abstract][Full Text] [Related]
15. Development of membrane type-1 matrix metalloproteinase-specific activatable fluorescent probe for malignant tumor detection.
Shimizu Y; Temma T; Sano K; Ono M; Saji H
Cancer Sci; 2011 Oct; 102(10):1897-903. PubMed ID: 21718387
[TBL] [Abstract][Full Text] [Related]
16. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
17. In vivo imaging of membrane type-1 matrix metalloproteinase with a novel activatable near-infrared fluorescence probe.
Shimizu Y; Temma T; Hara I; Makino A; Kondo N; Ozeki E; Ono M; Saji H
Cancer Sci; 2014 Aug; 105(8):1056-62. PubMed ID: 24863849
[TBL] [Abstract][Full Text] [Related]
18. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.
Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M
J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139
[TBL] [Abstract][Full Text] [Related]
19. A novel strategy to tag matrix metalloproteinases-positive cells for in vivo imaging of invasive and metastatic activity of tumor cells.
Zhao T; Harada H; Teramura Y; Tanaka S; Itasaka S; Morinibu A; Shinomiya K; Zhu Y; Hanaoka H; Iwata H; Saji H; Hiraoka M
J Control Release; 2010 May; 144(1):109-14. PubMed ID: 20096316
[TBL] [Abstract][Full Text] [Related]
20. Rational design of caspase-responsive smart molecular probe for positron emission tomography imaging of drug-induced apoptosis.
Qiu L; Wang W; Li K; Peng Y; Lv G; Liu Q; Gao F; Seimbille Y; Xie M; Lin J
Theranostics; 2019; 9(23):6962-6975. PubMed ID: 31660080
[No Abstract] [Full Text] [Related]
[Next] [New Search]
